【News_EN】

2023/01/27

RevolKa's corporate website has been renewed

【News_EN】

2022/11/14

RevolKa has been selected as a member of the Google for Startups Cloud Program.

【News_EN】

2022/11/10

Presenting at Antibody Engineering & Therapeutics

【News_EN】

2022/10/13

Our advertisement feature was published in the online version of Nature

【News_EN】

2022/10/01

Started a joint research collaboration with Tokyo Medical and Dental University

【News_EN】 collab-EN

2022/03/24

Concluded a joint research agreement with Sumitomo Dainippon Pharma

【News_EN】 collab-EN